CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19. In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.
Metrics to compare | 060590 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship060590PeersSector | |
|---|---|---|---|---|
P/E Ratio | 37.2x | 8.6x | −0.5x | |
PEG Ratio | 0.32 | 0.01 | 0.00 | |
Price/Book | 1.4x | 0.7x | 2.6x | |
Price / LTM Sales | 0.7x | 0.7x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 46.2% | |
Fair Value Upside | Unlock | 17.6% | 6.6% | Unlock |